Tubulis GmbH
acquired by Gilead SciencesPlanegg-Martinsried, DE · 15 known investors
Find your way into Tubulis GmbH
Sign up to see every warm intro you have to Tubulis GmbH
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tubulis GmbH team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tubulis develops antibody-drug conjugates (ADCs) for cancer treatment, using proprietary conjugation platform technologies to create tumor-targeting therapeutics. The company operates in the biotech/oncology drug development industry, with sites in Munich, Cambridge (MA), and Lausanne.
Founders & leadership
Investors · 15
How we know: Andera Partners's portfolio page · the company's own site · a partner's Signal profile · Not right? Tell us
How we know: BioMedPartners's portfolio page · the company's own site · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · a partner's Signal profile · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: Ascenta Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Bayern Kapital's portfolio page · Not right? Tell us
How we know: coparion's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Nextech Invest's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Seventure Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries COct 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Tubulis GmbH went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Tubulis GmbH.
Frequently asked questions
- What does Tubulis GmbH do?
- Tubulis develops antibody-drug conjugates (ADCs) for cancer treatment, using proprietary conjugation platform technologies to create tumor-targeting therapeutics. The company operates in the biotech/oncology drug development industry, with sites in Munich, Cambridge (MA), and Lausanne.
- Who founded Tubulis GmbH?
- Tubulis GmbH was founded by Dominik Schumacher.
- Who are Tubulis GmbH's investors?
- Tubulis GmbH's investors include Andera Partners, BioMedPartners, EQT Life Sciences, NexTech Ventures, Ascenta Capital, Bayern Kapital, coparion, Frazier Life Sciences and 7 more.
- Who acquired Tubulis GmbH?
- Tubulis GmbH was acquired by Gilead Sciences.
- Where is Tubulis GmbH headquartered?
- Tubulis GmbH is headquartered in Planegg-Martinsried, DE.











